0001415889-22-002616.txt : 20220304 0001415889-22-002616.hdr.sgml : 20220304 20220304200536 ACCESSION NUMBER: 0001415889-22-002616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABINOWITZ DANIEL CENTRAL INDEX KEY: 0001857843 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 22715940 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 13011 MCCALLEN PASS BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-03042022_080311.xml X0306 4 2022-03-02 0001604821 Natera, Inc. NTRA 0001857843 RABINOWITZ DANIEL C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false SEC. AND CHIEF LEGAL OFFICER Common Stock 2022-03-02 4 A 0 6450 0 A 144497 D Common Stock 2022-03-04 4 F 0 3461 58.3911 D 141036 D On April 12, 2019, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 12,900 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On March 2, 2022, the milestones were satisfied for the vesting of RSUs covering the remaining 6,450 shares of Common Stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.78 to $58.4006 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Tami Chen, Attorney-in-Fact 2022-03-04